ResearcherShanghai Jiao Tong UniversityNo recent work listed
Qiwei Zhang
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2021: 1 paper · 2022: 1 paper
Papers 2
- Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12094-022-02864-1↗
- OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives systemic antitumor immune response in a syngen… Co-author PMID 34249428↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yu Zhou · 2 shared papers, 2021–2022 · strength 0.30
- Paper Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal a… DOI 10.1007/s12094-022-02864-1↗
- Paper OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives system… PMID 34249428↗
- Xiaoyi Ding · 2 shared papers, 2021–2022 · strength 0.30
- Paper Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal a… DOI 10.1007/s12094-022-02864-1↗
- Paper OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives system… PMID 34249428↗
- Yongsheng Jiang · 1 shared paper, 2022 · strength 0.15
- Qingbing Wang · 1 shared paper, 2021 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.